- Home
- GOSS vs AEYE Comparison
GOSS vs AEYE Comparison
Compare GOSS & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- AEYE
- Stock Information
- Founded
- GOSS 2015
- AEYE 2005
- Country
- GOSS United States
- AEYE United States
- Employees
- GOSS N/A
- AEYE N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- AEYE Computer Software: Prepackaged Software
- Sector
- GOSS Health Care
- AEYE Technology
- Exchange
- GOSS Nasdaq
- AEYE Nasdaq
- Market Cap
- GOSS 237.9M
- AEYE 205.3M
- IPO Year
- GOSS 2019
- AEYE N/A
- Fundamental
- Price
- GOSS $0.96
- AEYE $17.22
- Analyst Decision
- GOSS Strong Buy
- AEYE Strong Buy
- Analyst Count
- GOSS 5
- AEYE 5
- Target Price
- GOSS $9.20
- AEYE $29.10
- AVG Volume (30 Days)
- GOSS 1.0M
- AEYE 253.3K
- Earning Date
- GOSS 03-04-2025
- AEYE 03-05-2025
- Dividend Yield
- GOSS N/A
- AEYE N/A
- EPS Growth
- GOSS N/A
- AEYE N/A
- EPS
- GOSS N/A
- AEYE N/A
- Revenue
- GOSS $105,322,000.00
- AEYE $33,348,000.00
- Revenue This Year
- GOSS N/A
- AEYE $14.66
- Revenue Next Year
- GOSS N/A
- AEYE $21.01
- P/E Ratio
- GOSS N/A
- AEYE N/A
- Revenue Growth
- GOSS N/A
- AEYE 6.94
- 52 Week Low
- GOSS $0.50
- AEYE $4.52
- 52 Week High
- GOSS $1.60
- AEYE $34.85
- Technical
- Relative Strength Index (RSI)
- GOSS 54.23
- AEYE 49.44
- Support Level
- GOSS $0.83
- AEYE $13.61
- Resistance Level
- GOSS $1.18
- AEYE $16.48
- Average True Range (ATR)
- GOSS 0.10
- AEYE 1.12
- MACD
- GOSS -0.01
- AEYE 0.46
- Stochastic Oscillator
- GOSS 41.37
- AEYE 94.26
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's, and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.